Amanda Gilkes

6PUBLICATIONS
64CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Mutational Signatures and Machine Learning for Risk Stratification of Acute Myeloid Leukaemia Based on Targeted Sequencing Data.

|Jun 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial.

|Sep 11, 2025
Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survival.

Farideh Miraki-Moud, Linda Ariza-McNaughton, Thinzar KoKo

|Jul 03, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.

Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard

|Nov 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.

Nigel H Russell, Abin Thomas, Robert K Hills

|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.

Jurjen Versluis, Marlen Metzner, Ariel Wang

Pageof 1

Frequent Collaborators

3 joint publications

Steven Knapper

3 joint publications

Abin Thomas

3 joint publications

Sylvie D Freeman

3 joint publications

Nigel Russell